BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9323935)

  • 21. Tissue factor increases in the aqueous humor of proliferative diabetic retinopathy.
    Sakamoto T; Ito S; Yoshikawa H; Hata Y; Ishibashi T; Sueishi K; Inomata H
    Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):865-71. PubMed ID: 11789868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics.
    Clermont AC; Cahill M; Salti H; Rook SL; Rask-Madsen C; Goddard L; Wong JS; Bursell D; Bursell SE; Aiello LP
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2701-8. PubMed ID: 16723489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats.
    Horio N; Clermont AC; Abiko A; Abiko T; Shoelson BD; Bursell SE; Feener EP
    Diabetologia; 2004 Jan; 47(1):113-23. PubMed ID: 14618237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats.
    Bursell SE; Clermont AC; Shiba T; King GL
    Curr Eye Res; 1992 Apr; 11(4):287-95. PubMed ID: 1388117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats.
    Bursell SE; Clermont AC; Oren B; King GL
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):596-607. PubMed ID: 7890491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat.
    Hammes HP; Lin J; Bretzel RG; Brownlee M; Breier G
    Diabetes; 1998 Mar; 47(3):401-6. PubMed ID: 9519746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
    Gilbert RE; Kelly DJ; Cox AJ; Wilkinson-Berka JL; Rumble JR; Osicka T; Panagiotopoulos S; Lee V; Hendrich EC; Jerums G; Cooper ME
    Diabetologia; 2000 Nov; 43(11):1360-7. PubMed ID: 11126403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline Factors Associated with Diabetic Retinopathy Improvement in RIDE/RISE.
    Dhoot DS; Hill LF; Ghanekar A; Tarnowski KW; Ali FS
    Ophthalmol Retina; 2021 Jan; 5(1):101-103. PubMed ID: 32688084
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation of retinal vascular perfusion density with dark adaptation in diabetic retinopathy.
    Hsiao CC; Hsu HM; Yang CM; Yang CH
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1401-1410. PubMed ID: 31001668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.
    Funatsu H; Yamashita H; Ikeda T; Nakanishi Y; Kitano S; Hori S
    Am J Ophthalmol; 2002 Apr; 133(4):537-43. PubMed ID: 11931788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C; Ortega N; Bayard F; Plouet J
    Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
    Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats.
    Stitt AW; Bhaduri T; McMullen CB; Gardiner TA; Archer DB
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):380-8. PubMed ID: 11032761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.
    Hofman P; van Blijswijk BC; Gaillard PJ; Vrensen GF; Schlingemann RO
    Arch Ophthalmol; 2001 Jun; 119(6):861-6. PubMed ID: 11405837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ULTRAHIGH SPEED SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL AND CHORIOCAPILLARIS ALTERATIONS IN DIABETIC PATIENTS WITH AND WITHOUT RETINOPATHY.
    Choi W; Waheed NK; Moult EM; Adhi M; Lee B; De Carlo T; Jayaraman V; Baumal CR; Duker JS; Fujimoto JG
    Retina; 2017 Jan; 37(1):11-21. PubMed ID: 27557084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.